In summary, our findings indicate that S100A4, SLC7A11, PRDX1, SLC7A7, and DIAPH3 may have prognostic significance in PAAD and are associated with immune infiltration levels. This evidence concerns the gene SLC7A11 and pancreatic adenocarcinoma.